Kyowa Kirin gets EC approval for CRYSVITA (burosumab) to treat X-Linked hypophosphataemia in older adolescents and adults Read more
Oral GnRH antagonists have potential in female health beyond endometriosis pain and uterine fibroids Read more
Drug makers, BMGF pledge to strive for global access to COVID-19 diagnostics, therapeutics and vaccines Read more